Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction

NCT06812546 is registered in ClinicalTrials.gov with Dongying Zhang as lead sponsor.

NCT NCT06812546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction
Lead sponsor
Dongying Zhang
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 1, 2025
Completion date
December 30, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure (ahf), acute myocardial infarction (ami), heart failure